Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05374304 · ClinicalTrials.gov registry record · NA

Decision Making for Older Adults With Cancer

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
65
Enrollment target

NCT05374304 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 65 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05374304, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

This is a minimal risk, pilot cluster randomized controlled trial (CRT) to determine the feasibility and acceptability of training medical oncologists to use the Best Case/Worst Case-Geriatric Oncology (BC/WC-GeriOnc) communication tool in clinical practice with older adults with cancer.

Interventions

  • OTHER Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2022-07-06
Est. Completion 2025-01-22
Phase NA

What the Registry Record Tells You About NCT05374304

The ClinicalTrials.gov registry entry for NCT05374304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool is the first listed.

NCT05374304 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05374304 about?

NCT05374304 is a clinical study titled "Decision Making for Older Adults With Cancer". This is a minimal risk, pilot cluster randomized controlled trial (CRT) to determine the feasibility and acceptability of training medical oncologists to use the Best Case/Worst Case-Geriatric Oncology (BC/WC-GeriOnc) communication tool in clinical practice with older adults with cancer.

What is the current status of trial NCT05374304?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2022-07-06. Estimated completion is 2025-01-22.

What interventions are being tested in trial NCT05374304?

The interventions under investigation include: Best Case/Worst Case (BC/WC) Geriatric Oncology (GeriOnc) communication tool (OTHER).

Who is sponsoring clinical trial NCT05374304?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.